ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 38,205 | 38,525 | 31,337 | 20,555 | 18,035 |
| Cost of Goods | 16,906 | 16,669 | 11,795 | 3,410 | 3,540 |
| Gross Profit | 21,299 | 21,856 | 19,542 | 17,145 | 14,495 |
| Operating Expenses | 20,907 | 14,604 | 15,143 | 11,889 | 8,767 |
| Operating Income | 1,298 | 7,921 | 5,194 | 5,666 | 6,268 |
| Interest Expense | 2,859 | 2,856 | 2,830 | 2,782 | 2,768 |
| Other Income | -43 | -21 | -12 | 2 | 1 |
| Pre-tax Income | -1,604 | 5,044 | 2,352 | 2,886 | 3,501 |
| Income Tax | -524 | 2,501 | 1,227 | 1,540 | 625 |
| Net Income Continuous | -1,080 | 2,543 | 1,125 | 1,346 | 2,876 |
| Net Income | $-1,080 | $2,543 | $1,125 | $1,346 | $2,876 |
| EPS Basic Total Ops | -0.10 | 0.22 | 0.10 | 0.12 | 0.25 |
| EPS Basic Continuous Ops | -0.09 | 0.22 | 0.10 | 0.12 | 0.25 |
| EPS Diluted Total Ops | -0.10 | 0.22 | 0.10 | 0.12 | 0.24 |
| EPS Diluted Continuous Ops | -0.09 | 0.22 | 0.10 | 0.12 | 0.25 |
| EBITDA(a) | $7,110 | $13,887 | $11,150 | $10,275 | $8,379 |